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ABSTRACT
Background and aims Little is known about the long-term economic consequences of smoking during pregnancy. We
estimated the association between smoking in pregnancy and the costs of delivering health-care to infants and children in
England, and investigated which aspects of care are the key drivers of these costs. Methods We used Hospital Episode
Statistics (HES) linked with Clinical Practice Research Datalink (CPRD) data in England from January 2003 to January
2015 in children with longitudinal data for at least 1, 5 and 10 years after birth. Poisson regression provided rate ratios
(RR) and 95% conﬁdence intervals (CIs) comparing health-care episode rates between those exposed and not exposed
to smoking during pregnancy. Linear regression was used to compare estimated costs between groups (£ sterling, 2015
prices) and generalized linear multivariable (GLM) models adjusted for potentially moderating factors. Results A total
of 93152 singleton pregnancies with the required data were identiﬁed. Maternal smoking in pregnancy was associated
with higher primary care, prescription and hospital in-patient episode rates, but lower out-patient visit and diagnostic test
rates. Adjusting for year of birth, socio-economic deprivation, parity, sex of child and delivery method showed that mater-
nal smoking in pregnancy was associated with increased child health-care costs at 1 year [average cost difference for
children of smokers, β = £91.18, 95% conﬁdence interval (CI) = £47.52–134.83 and 5 years of age (β = £221.80,
95% CI = £17.78–425.83], but not at 10 years of age (β = £365.94, 95% CI = –£192.72 to £924.60). Conclusion In
England, maternal smoking in pregnancy is associated with increased child health-care costs over the ﬁrst 5 years of life;
these costs are driven primarily by greater hospital in-patient care.
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INTRODUCTION
In Europe, the prevalence of smoking during pregnancy
has been estimated to vary from 4.2% in Iceland to
18.9% in Croatia [1]. Maternal smoking during pregnancy
is associated withmany adverse infant and child outcomes,
including an elevated risk of asthma, respiratory illness,
sudden infant death syndrome (SIDS), behavioural difﬁcul-
ties [attention deﬁcit hyperactivity disorder (ADHD)],
preterm delivery and low birth weight, as well as poor
maternal outcomes such as ectopic pregnancy andmiscar-
riage [2–4]. These adverse sequelae are likely to increase
the costs of health care for children born to pregnant
smokers.
Few studies have quantiﬁed the additional burden on
health-care services for infants and children, which is
attributable to smoking in pregnancy [5–9]. Godfrey et al.
estimated the additional smoking-related costs to the UK
National Health Service (NHS) incurred by infants during
the ﬁrst 12 months of life as between £12 and £23.5
million annually (2006 prices) [7]. However, this work
used literature-based estimates for costs arising from only
selectedmorbidities believed to be associatedwith smoking,
rather than deriving cost estimates for all health-care use.
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Petrou et al. used medical record linkage to investigate
children’s excess hospital in-patient costs attributable to
smoking in pregnancy during their ﬁrst 5 years of life [9],
and other studies investigating this subject have similarly
been restricted to estimating speciﬁc elements of overall
health-care use, such as neonatal intensive care admis-
sions or health care during very early childhood [5,6,8].
We could ﬁnd no studies which investigated infants’ and
children’s health-care costs attributable to smoking in
pregnancy, which included a consideration of most
health-care episodes including those in hospital out-patient
and primary care.
The primary aim of this paper was to estimate the
impact of maternal smoking during pregnancy on the
total cost of providing health-care services for children.
This was carried out using English data from the UK
NHS, a public provider of care in England, Scotland, Wales
and Northern Ireland. The government’s annual NHS
budget is more than £90 billion, and care is provided free
at the point of use [10]. The structure varies in individual
countries, but all provide primary [community care,
general practitioners (GPs), pharmacists], secondary
(hospital-based access via referral) and tertiary (specialist
hospital facilities) care [10]. We used long-term, compre-
hensive, prospective and routinely collected data to investi-
gate children’s use and cost of GP services, including
consultations, prescriptions and diagnostic tests, along
with hospital care services. Our secondary aim was to
determine the distribution of costs borne by primary and
secondary care providers.
METHODS
Data sources
UK-wide Clinical Practice Research Datalink (CPRD)
[11], Hospital Episode Statistics (HES) [12], Ofﬁce for
National Statistics (ONS) mortality data [13] and Index
of Multiple Deprivation (IMD) data were used (linked data
provided by CPRD) [14]. The study was approved by the
CPRD Independent Scientiﬁc Advisory Committee (ISAC,
protocol number: 15_186R). CPRD contains more than
13 million anonymized primary care medical records
from 684 UK general practices; prospectively collected
records are available from 1987. Linked records are
available for approximately 10 million patients in 398
practices. Linked HES in-patient data are available from
1997, linked HES out-patient data from 2003 and ONS
mortality data from 1998 onwards. The IMD is an
indicator of deprivation socio-economic status (SES)
based on census information from the patients’ home
postcodes grouped into lower super output areas (LSOA);
each LSOA covers approximately 1500 residents/650
households.
Cohort of children born to pregnant smokers and
non-smokers
We included children born in England following singleton
pregnancies who had up-to-standard linked CPRD-HES
data, with at least 1, 5 or 10 years of follow-up from birth
and whose mothers were aged 13–49 years at delivery.
Mothers and children were identiﬁed ﬁrst from the CPRD
mother–baby link; we included women with a CPRD
record of smoking status or use of smoking cessation
medications in pregnancy. As records of smoking status
in pregnancy are generally valid [15], we were conﬁdent
that using these attributions of exposure or non-exposure
to smoking in pregnancy would be generally correct. The
study ran from January 2003 to January 2015, when both
in-patient and out-patient CPRD-linked HES data were
available. Data on delivery method, parity, gestation and
delivery dates, sex of the baby and IMDwere extracted from
HES. Children’s duration of follow-up was measured from
birth until death, transfer out of a CPRD general practice
or the end of the study period, whichever was earliest,
and individual children had data available for different
lengths of time. To minimize any cluster effects, if a woman
had more than one child during the follow-up period only
one was selected randomly for inclusion.
Exposure deﬁnitions
Smoking in pregnancy. Children were considered exposed to
smoking in pregnancywhen born towomenwho, between
conception and delivery, had one or more smoking
Medcodes or Multilex codes for smoking cessation medica-
tion prescriptions (i.e. NRT, bupropion, varenicline)
recorded in CPRD. This method has been used previously
in a study using The Health Improvement Network (THIN)
database [16].
Not smoking in pregnancy. Children were considered not
exposed to smoking in pregnancy if their mother had a
Medcode for being a non-smoker (including ex-smokers)
recorded in CPRD during the gestational period. Consistent
with the guidelines for attributing smoking status used by
the UK Quality and Outcomes Framework (QOF) [17],
women were also considered non-smokers if they were
recorded as such at least three times before the age of
25 years, or before becoming pregnant, had been recorded
as an ex-smoker in 3 or more consecutive years. Addition-
ally, during pregnancy, women could not be issued with
smoking pharmacotherapy prescriptions.
Primary care consultation costing
Different primary care events held with a health-care
professional on the same date were classiﬁed as one consul-
tation, and costs were attributed to consultations using the
2015 Personal Social Services Research Unit (PSSRU)
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reference costs [18]; attribution was based on the type of
health-care professional providing the consultation (see be-
low) and the consultation setting (i.e. surgery, home visit,
clinic, out-of-hours, telephone). Primary health-care con-
sultations were deﬁned as those with GP partners/senior
partners, registrars, locums or sole practitioners,
community/practice nurses and dispensers/pharmacists.
Where the 2015 PSSRU unit cost compendium provided
no unit cost for a provider and setting combination, this
was taken instead from the most recent PSSRU unit cost
compendia and adjusted to 2015 prices using the NHS
Hospital and Community Health Services Pay and Price
Index [18].
Prescription costing
We recorded children’s prescription items and used the
British National Formulary (BNF) to cost prescriptions at
the BNF chapter subparagraph level [19]. BNF chapters
relate to body systems, BNF sections to prescribing for sys-
tems, and paragraph and subparagraph levels relate to the
pharmacology and therapeutic use. The Prescription Cost
Analysis (PCA) database for 2015 [20] was used to attri-
bute all prescription costs, irrespective of the year in which
they were issued. Where the 2015 PCA database did not
specify costs for items prescribed (32.3% of all prescrip-
tions), the average 2015 PCA prescription cost (£30.96)
was used.
Primary care diagnostic test costing
Children’s diagnostic tests in the CPRD test ﬁle were
identiﬁed and included. Costs for diagnostic tests were
based on those listed in the National Schedule of Reference
Costs (2015) for direct access pathology and diagnostic
services [18]. Average costs were assigned for asthma tests
(e.g. lung function/spirometry), biochemistry (e.g. hor-
mone, thyroid function, electrolytes), diabetic retinopathy,
diagnostic imaging (e.g. chest X-ray), haematology (e.g. full
blood count, clotting tests), microbiology (e.g. stool
culture, sputumculture),histology,otherpathologyservices
(e.g. sputum cytology, urine cytology) and serology and
immunology (e.g. immunoglobin tests, rubella/tuberculin
tests). Individual costs, inﬂated to 2015 prices where
necessary,wereassigned toeachdiagnostic test (e.g. electro-
cardiogram, diagnostic bone marrow extraction, etc.).
Secondary care costing
Secondary care encounters were derived from HES in-
patient and out-patient data. HES in-patient data were
extracted and each hospital admission was identiﬁed by a
unique spell number. HES in-patient data were then
reformatted to apply appropriate reference costs to admis-
sions using the national tariff prices, based on the national
average unit service provision costs taken from the 2015
National Schedule of Reference Costs [18]. This was
achieved by using the hierarchical algorithm in the Health
Resource Group (HRG) 4 2015/16 Local Payment Grouper
programme [21], provided by the Health and Social Care
Information Centre (HSCIC). This programme applied
HRG codes to care episodes, which were linked to NHS
tariff costs [18]. HRG codes were generated for each
episode of in-patient care experienced by children, and
the sum of NHS tariff costs for these episodes was calcu-
lated for each child.
HES out-patient data were extracted by the CPRD
Knowledge Centre [11]; 3.4% of out-patient episodes were
costed using the HSCIC Grouper, while the majority
(90.7%) of out-patient episodes were costed using treat-
ment speciality average costs from the relevant NHS refer-
ence cost schedules. The remaining 5.9% of episodes had
an average out-patient cost applied (£147.30), as they
could not be costed by Grouper or treatment speciality.
Reference costs for secondary NHS care in the United
Kingdom are calculated on a full absorption costing
basis and encompass staff salaries, on-costs, equipment,
consumables and revenue and capital overheads.
Statistical analysis
Our primary aim was to compare health-care costs among
children born to women who smoked and non-smokers in
pregnancy within the ﬁrst, the ﬁrst 5 and the ﬁrst 10 years
of life; hence, ﬁndings are presented in cohorts with at least
1, 5 or 10 years of follow-up data available. Descriptive
statistics of baseline maternal demographic characteristics
for pregnancies were calculated, including the numbers of
children with 1, 5 and 10 years of cohort data available,
and the proportions of each born to smoking and non-
smoking mothers.
Poisson regression was used to compute annualized
rate ratios (RRs) and 95% conﬁdence intervals (CIs) for
the association between smoking status and each compo-
nent of primary and secondary health care. Numbers of
primary and secondary care health-care episodes used
were collapsed into counts which were analysed cross-
sectionally in these Poisson models. The analysis was
stratiﬁed by factors considered to potentially affect chil-
dren’s health-care use: maternal age (< 20, 20–24,
25–29, 30–34 and ≥ 35 years), parity (0 or ≥ 1 children),
SES (IMD quintiles), sex of infant (male, female) and mode
of delivery (spontaneous, assisted, elective caesarean,
emergency caesarean). Furthermore, year of birth was
adjusted for to allow for the possibility that the volume
and or pattern of health care provided to infants and
children might have evolved through the course of each
cohort, as well as the recorded prevalence of maternal
smoking. As analyses employed multiple signiﬁcance
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testing of strata on the same health-care outcome, a
Bonferroni correction was applied to tests at the 99.7%
conﬁdence level (i.e. α = 0.05/19, P ≤ 0.003, 19 = number
of signiﬁcance tests per outcome) to determine the
signiﬁcance of each association. The mean and standard
deviations for the number of encounters were also
calculated for each stratum.
Linear regression was used to compute coefﬁcients and
95% CIs for the association between maternal smoking
during pregnancy and the estimated costs of child health-
care utilization, adjusting for year of birth. The absolute
difference in average annual cost between children of
smoking and non-smoking mothers was calculated. A
similar Bonferroni correction was applied to the costs as
to the previous analysis of health-care utilization. In the
Supplementary information, ﬁndings are also presented
in strata for maternal age, parity, SES, sex of child and
delivery method. As little is known about the costs
attributable to smoking in primary and secondary care,
especially beyond 5 years of follow up, this stratiﬁed analy-
sis was carried out to present the ﬁndings in a descriptive
way by these variables. Stratiﬁcation of the follow-up into
1, 5 and 10-year periods was chosen based on prior
knowledge; costing in the ﬁrst year is important, as utiliza-
tion during infancy may be associated with longer-term
costs. The ﬁrst 5 years is a marker that is used commonly
in the United Kingdom and partially by the World Health
Organization (WHO), as children start formal schooling at
approximately age 5 and allows a comparison to other
studies, and 10-year follow-up was the longest available
with a signiﬁcant number of participants to analyse.
In each cohort the variation in total health-care costs
for children of women who smoked in pregnancy, versus
those who did not, was assessed using a multivariable
generalized linear model (GLM) to generate cost coefﬁ-
cients and 95% CIs. The association between smoking in
pregnancy and overall health-care cost was adjusted for
year of birth, maternal age, IMD, parity, sex of infant and
mode of birth. A gamma distribution and ﬁtted robust
standard errors were applied. We further replicated the
GLM models over 1- and 5-year time horizons, restricting
the sample to those who had complete 10-year data, to
investigate whether the effects of smoking during preg-
nancy waned or persisted in the reduced sample size with
complete follow-up data.
Where data were missing for the stratiﬁcation covari-
ates for the multivariable models (maternal age, SES,
parity, infant gender or mode of delivery) or for outcomes
(described below), individuals were excluded from analy-
ses. A comparative analysis investigating the distribution
of the baseline covariates was performed to investigate
whether removal of these cases biased the sample. Analy-
ses were conducted using Stata version 14.0 (Stata
Corporation, College Station, TX, USA).
RESULTS
Cohort selection
There were 586017 pregnancies with ‘up-to-standard’
CPRD-HES data from January 2003 onwards; 244012 of
these women had sufﬁcient data to attribute smoking
status within the pregnancy; 203159 of these pregnancies
had the minimum length of child follow-up (1 year). Of
these children, 137737 had the necessary HES-linked
secondary care data and 44585 children were excluded
randomly, as they were siblings and shared a mother. No
participants were excluded due to there being missing data
for other baseline maternal covariates. Therefore, the ﬁnal
cohort comprised 93152 children, 21.8% of whom were
born to women who had smoked in pregnancy.
Cohort characteristics
A total of 34260 children had at least 5 years’ and 5824 at
least 10 years’ data. Approximately one-ﬁfth of children in
5- and 10-year cohorts were children of maternal smokers.
The largest proportion of mothers fell into the 30–34-year
age range in each cohort. The proportions of children
exposed to maternal smoking during pregnancy stratiﬁed
by maternal age, IMD, parity, infant sex and mode of birth
are listed in Table 1. In all three cohorts, women who
smoked during pregnancy were, on average, younger and
resided in more deprived areas. A slightly higher propor-
tion of ﬁrst-time mothers smoked during pregnancy. A
higher proportion of male children were contained in each
of the follow-up cohorts and this did not differ by maternal
smoking status. Finally, non-smoking mothers had a lower
spontaneous vaginal delivery rate and a higher proportion
had an instrumental delivery or a caesarean section; this
may be attributable to the greater average age of mothers
who did not smoke during pregnancy.
Comparison of health-care utilization by smokers’ and
non-smokers’ children
Table 2 presents the adjusted annual RRs for primary and
secondary care health-care utilization by children of rate
ratios for year of birth, maternal age, parity, SES,
gender of child and delivery method. In the whole
cohort, infants exposed to maternal smoking in pregnancy
had higher primary care consultation (RR = 1.015, 95%
CI = 1.007–1.022) and in-patient admission (RR = 1.040,
95% CI = 1.020–1.060) rates during the ﬁrst year of life.
In children for whom at least 5 years’ data were
available, those born to pregnant smokers had higher an-
nual primary care (RR = 1.021, 95% CI = 1.005–1.038)
and out-patient consultation (RR = 1.084, 95%
CI = 1.036–1.134) rates, but a lower annual primary care
diagnostic test rate (RR = 0.961, 95% CI = 0.924–0.999)
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during the ﬁrst 5 years of life. Finally, in those with at least
10 years’ follow-up data, children born to pregnant
smokers had higher annual primary care (RR = 1.062,
95% CI = 1.012–1.114) and out-patient consultation
(RR = 1.126, 95% CI = 1.001–1.267) rates during
the ﬁrst 10 years of life. The risk ratios presented in
Table 2 stratiﬁed by confounding factors, and Bonferroni-
corrected, are presented in Supporting information,
Table S1a–c.
Comparison of health-care costs incurred by smokers’ and
non-smokers’ children
Table 3 compares overall estimated health-care costs
incurred by children of women who smoked and did not
smoke in pregnancy, disaggregating costs for different
health-care components. All associations were adjusted
by year or birth, maternal age, parity, SES, gender of child
and delivery method.
Smoking during pregnancy had the greatest inﬂuence
on hospital in-patient costs, which were signiﬁcantly
greater for children whose mothers smoked during
pregnancy (β = £93.95, 95% CI = £39.44–148.45)
during the ﬁrst year of life. For all other aspects of
health-care utilization (primary care, diagnostic tests, pre-
scriptions and out-patient care), including for the 5- and
10-year cohorts, there were no signiﬁcant differences in
costs between the children whose mothers either smoked
or did not smoke during pregnancy. The coefﬁcients
presented in Table 3, stratiﬁed by confounding factors
and Bonferroni-corrected, are presented in Supporting
information, Table S2a–c.
Investigation of factors inﬂuencing costs: multivariable
GLM model
Table 4 presents multivariable GLM models for children
with at least 1, 5 and 10 years of follow-up data, with
total health-care costs as the dependent variable.
Following adjustment for year of birth, IMD, parity,
sex of child and delivery method, maternal smoking
in pregnancy was associated with signiﬁcantly higher
total health-care costs during the ﬁrst (β = £91.18,
95% CI = £47.52–134.83) and also the ﬁrst 5
(β = £221.80, 95% CI = £17.78–425.83) years of
life, but not during the ﬁrst 10 years (β = 365.94,
95% CI = –192.72 to 924.60). During the ﬁrst year of life,
boys had greater total health-care costs compared to girls
Table 1 Maternal and child characteristics according to mother’s smoking status during pregnancy.
At least 1 year’s follow-upb At least 5 years’ follow-up At least 10 years’ follow-up
Non-smokers (%) Smokers (%) Non-smokers (%) Smokers (%) Non-smokers (%) Smokers (%)
Overall 72863 (78.2)a 20289 (21.8)a 26 958 (78.7)a 7302 (21.3)a 4666 (80.1)a 1158 (19.9)a
Maternal age (years)
< 20 2475 (3.4) 2188 (10.8) 797 (3.0) 790 (10.8) 121 (2.6) 105 (9.1)
20–24 9298 (12.8) 5548 (27.3) 3178 (11.8) 1879 (25.7) 538 (11.5) 273 (23.6)
25–29 19352 (26.6) 5516 (27.2) 6693 (24.8) 1871 (25.6) 1128 (24.2) 304 (26.3)
30–34 24690 (33.9) 4368 (21.5) 9224 (34.2) 1655 (22.7) 1668 (35.8) 305 (26.3)
≥ 35 17048 (23.4) 2669 (13.2) 7066 (26.2) 1107 (15.2) 1211 (26.0) 171 (14.8)
Socio-economic status: Index of Multiple Deprivation
1 (least deprived) 18142 (24.9) 2585 (12.7) 7550 (28.0) 1019 (14.0) 1442 (30.9) 174 (15.0)
2 15735 (21.6) 3195 (15.8) 6053 (22.5) 1203 (16.5) 1110 (23.8) 197 (17.0)
3 13872 (19.0) 3855 (19.0) 5028 (18.7) 1376 (18.8) 864 (18.5) 232 (20.0)
4 13789 (18.9) 4968 (24.5) 4668 (17.3) 1788 (24.5) 735 (15.8) 278 (24.0)
5 (most deprived) 11325 (15.5) 5686 (28.0) 3659 (13.6) 1916 (26.2) 515 (11.0) 277 (23.9)
Parity
0 42358 (58.1) 12370 (61.0) 11 774 (43.7) 3370 (46.2) 1842 (39.5) 461 (39.8)
≥ 1 30505 (41.9) 7919 (39.0) 15 184 (56.3) 3932 (53.9) 2824 (60.5) 697 (60.2)
Sex of child
Female 34585 (47.5) 9620 (47.4) 12 533 (46.5) 3411 (46.7) 2107 (45.2) 543 (46.9)
Male 38278 (52.5) 10669 (52.6) 14 425 (53.5) 3891 (53.3) 2559 (54.8) 615 (53.1)
Delivery method
Spontaneous vaginal
delivery
42756 (58.7) 13068 (64.4) 15 999 (59.4) 4736 (64.9) 2729 (58.5) 756 (65.3)
Assisted delivery 10693 (14.7) 2513 (12.4) 3491 (13.0) 848 (11.6) 618 (13.2) 126 (10.9)
Elective caesarean 7769 (10.7) 1724 (8.5) 3178 (11.8) 658 (9.0) 575 (12.3) 108 (9.3)
Emergency caesarean 11645 (16.0) 2984 (14.7) 4290 (15.9) 1060 (14.5) 744 (16.0) 168 (14.5)
aRow percentage, otherwise column percentage; bfollow-up at 1 year constitutes entire study cohort.
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Table 2 Adjusted annual rate ratios for primary and secondary health-care utilization for children whose mothers were smokers
compared to non-smokers during pregnancy.
Number of primary care
consultations, mean (median) 95% CI
Non-smoking Smoking RRa Lower Upper
(0–1 year’s follow-up for those with at least 1-year
follow-up data) (n = 93152)
12.17 (10) 12.36 (11) 1.015 1.007 1.022
(0–5 years’ follow-up for those with at least 5 years’
follow-up data) (n = 34260)
31.59 (27) 32.17 (27) 1.021 1.005 1.038
(0–10 years’ follow-up for those with at least 10 years’
follow-up data) (n = 5824)
42.73 (35) 45.57 (37) 1.062 1.012 1.114
Number of prescriptions,
mean (median) 95% CI
Non-smoking Smoking RRa Lower Upper
(0–1 year’s follow-up for those with at least 1-year
follow-up data) (n = 93152)
5.04 (3) 5.15 (3) 1.005 0.994 1.016
(0–5 years’ follow-up for those with at least 5 years’
follow-up data) (n = 34260)
15.62 (10) 15.45 (11) 0.980 0.959 1.003
(0–10 years’ follow-up for those with at least 10 years’
follow-up data) (n = 5824)
23.71 (15) 24.64 (17) 1.016 0.953 1.084
Number of diagnostic tests,
mean (median) 95 % CI
Non-smoking Smoking RRa Lower Upper
(0–1 years’ follow-up for those with at least 1-year
follow-up data) (n = 93152)
2.26 (1) 2.19 (1) 0.990 0.974 1.006
(0–5 years’ follow-up for those with at least 5 years’
follow-up data) (n = 34260)
5.56 (1) 5.32 (1) 0.961 0.924 0.999
(0–10 years’ follow-up for those with at least 10 years’
follow-up data) (n = 5824)
9.33 (2) 9.98 (3) 1.078 0.974 1.193
In-patient, mean (median)b 95 % CI
Non-smoking Smoking RRa Lower Upper
(0–1 years’ follow-up for those with at least 1-year
follow-up data) (n = 93152)
1.54 (1) 1.63 (1) 1.040 1.020 1.060
(0–5 years’ follow-up for those with at least 5 years’
follow-up data) (n = 34260)
2.09 (1) 2.27 (1) 1.048 0.986 1.114
(0–10 years’ follow-up for those with at least 10 years’
follow-up data) (n = 5824)
2.38 (1) 2.60 (2) 1.062 0.869 1.298
Out-patient, mean (median)b 95 % CI
Non-smoking Smoking RRa Lower Upper
(0–1 years’ follow-up for those with at least 1-year
follow-up data) (n = 93152)
1.11 (0) 1.07 (0) 1.004 0.981 1.028
(0–5 years’ follow-up for those with at least 5 years’
follow-up data) (n = 34260)
3.84 (1) 4.13 (1) 1.084 1.036 1.134
(0–10 years’ follow-up for those with at least 10 years’
follow-up data) (n = 5824)
6.65 (2) 7.63 (3) 1.126 1.001 1.267
Risk ratios in bold type are signiﬁcant at P ≤ 0.003. aPoisson regression rate ratios (RR) [95% conﬁdence interval (CI)] for number of consultations per year of
follow-up, adjusted for year of birth, maternal age, parity, socio-economic status (SES), gender of child and delivery method; bsecondary care consultations.
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Table 3 Primary care, secondary care and overall costs of health-care utilization accrued for children whose mothers were smokers
compared to non-smokers during pregnancy.
Cost of primary care consultations,
mean (median)a 95% CI
Non-smoking Smoking β Lower Upper
Costs for children at 1 year with at least 1 year of
follow-up (n = 93152)
192 (166) 193 (167) 1.11 1.86 4.07
Costs for children at 5 years with at least 5 years of
follow-up (n = 34260)
508 (435) 513 (440) 6.97 6.60 20.56
Costs for children at 10 years with at least 10 years
of follow-up (n = 5824)
705 (592) 742.12 (634) 31.62 16.59 79.84
Cost of prescriptions,
mean (median)a 95% CI
Non-smoking Smoking β Lower Upper
Costs for children at 1 year with at least 1 year of
follow-up (n = 93152)
324 (177) 330 (187) 0.30 11.81 12.40
Costs for children at 5 years with at least 5 years of
follow-up (n = 34260)
1063 (588) 1060 (617) 6.51 85.10 72.08
Costs for children at 10 years with at least 10 years
of follow-up (n = 5824)
1781 (868) 1847 (1028) 29.84 362.67 422.36
Cost of diagnostic tests,
mean (median)a 95 % CI
Non-smoking Smoking β Lower Upper
Costs for children at 1 year with at least 1 year of
follow-up (n = 93152)
21 (0) 22 (0) 1.72 0.27 3.71
Costs for children at 5 years with at least 5 years of
follow-up (n = 34260)
56 (4) 56 (1) 0.24 6.88 7.36
Costs for children at 10 years with at least 10 years
of follow-up (n = 5824)
124 (14) 126 (14) 0.18 40.77 41.14
In-patient, mean (median)a 95% CI
Non-smoking Smoking β Lower Upper
Costs for children at 1 year with at least 1 year of
follow-up (n = 93152)
755 (0) 862 (0) 93.95 39.44 148.45
Costs for children at 5 years with at least 5 years of
follow-up (n = 34260)
1299 (0) 1526 (604) 173.41 44.83 391.65
Costs for children at 10 years with at least 10 years
of follow-up (n = 5824)
1620 (595) 1841 (731) 152.69 489.51 794.90
Out-patient, mean (median)a 95% CI
Non-smoking Smoking β Lower Upper
Costs for children at 1 year with at least 1 year of
follow-up (n = 93152)
189 (0) 183 (0) 3.06 8.62 14.73
Costs for children at 5 years with at least 5 years
of follow-up (n = 34 260)
605 (193) 659 (193) 52.58 5.47 110.62
Costs for children at 10 years with at least 10 years
of follow-up (n = 5824)
1014 (382) 1181 (500) 135.10 81.34 351.54
Coefﬁcients in bold type are signiﬁcant at P ≤ 0.003. aRegression coefﬁcients for cost (£) adjusted for year of birth, maternal age, socio-economic status (SES),
parity, gender of child and delivery method. CI = conﬁdence interval.
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(β = £229.05, 95% CI = £196.00–262.10), while the
increasing intensity of the intervention delivery method
was also associated with greater costs (e.g. emergency
caesarean β = £655.39, 95% CI = £599.96–710.81).
Greater socio-economic deprivation was associated
with higher costs (5th IMD quintile: β = £79.03,
95% CI = £26.46–131.61), but increasing maternal age
was associated with lower total health-care costs (e.g. for
30–34-year-olds: β = –£117.16, 95% CI = –£167.58 to
–66.74). Compared to complete cohort ﬁndings, total
health-care costs during the ﬁrst 5 and ﬁrst 10 years of life
showed similar associations with delivery mode, sex of
child and IMD distribution. However, while maternal
age showed little or no effect on total costs of child
health-care during extended follow-up periods, multiparity
was associated with signiﬁcantly reduced total health-
care costs during the ﬁrst 10 years of life (£645.09,
95% CI = –£1195.04 to –95.14).
Following restriction of the GLM models to children
with complete 10 years’ follow-up data, the associations
were similar to those for the unrestricted analysis at 1 year
(β = 41.18, 95% CI = –£98.02 to 180.38) and 5 years
(β = £195.22, 95% CI = –£165.19 to 555.63); however,
the cost coefﬁcients did not reach statistical signiﬁcance.
DISCUSSION
Infants and children of pregnant smokers had higher
health-care costs during the ﬁrst 5 years of life, predomi-
nantly attributable to greater hospital in-patient care.
Although rates of primary care consultations, hospital
in-patient and hospital out-patient episodes were higher
in smokers’ children, our results indicate an inverse associ-
ation between smoking during pregnancy and the number
of diagnostic tests in primary care during the ﬁrst 5 years of
children’s lives. This apparent underutilization in the use of
some primary health care services may reﬂect differences
in health-seeking behaviour between mothers character-
ized by different socio-demographic proﬁles, but this
remains to be elucidated by future research studies in this
clinical context.
Strengths and limitations
Among studies evaluating health-care costs of children
born to pregnant smokers, this has the longest follow-up
and is the ﬁrst to investigate costs after 5 years of life.
Additionally, it is more comprehensive; we attempted to
measure use of all health care rather than, as in previous
studies, only assessing impacts generated by selected condi-
tions thought to be associated with smoking in pregnancy
[7] or taking only a secondary care perspective [9]. We be-
lieve this work is the ﬁrst to use multivariable methods to
identify key inﬂuences on children’s smoking-attributable
health-care costs.
A limitation is that we deﬁned the smoking status in
pregnancy from records of tobacco use and of smoking
cessation medication prescriptions in medical records,
and this involved some assumptions. Some women stop
smoking later in pregnancy, but our simpliﬁed classiﬁcation
of women as either ‘smoking’ or ‘not smoking’ for the
whole of pregnancy could not reﬂect this, and some
womenmay have been categorized as smoking throughout
pregnancy when they may only have smoked brieﬂy. How-
ever, patients usually provide accurate information to GPs
and we have demonstrated previously that assumptions
used in this study lead to valid attribution of smoking status
[15], so any misclassiﬁcation of smoking will be small and
study ﬁndings are likely to be valid. Additionally, asmisclas-
siﬁcation would tend to reduce apparent differences
between groups’ health-care cost estimates, ﬁndings are
conservative and actual cost differences may be larger. A
further limitation was the absence of comprehensive data
on the number of cigarettes smoked during pregnancy.
As data on this variable were only available in the records
of 22% of women, we did not account for this factor as this
would have reduced the sample size and precision of
estimates, especially for the analyses over an extended time
horizon for which we had fewer complete cases.
As women who smoke in pregnancy are likely to smoke
after childbirth, some of infants’ and children’s health-care
use in the smoking-exposed group may be attributable to
second-hand smoking (SHS). We decided not to attempt
to factor this into our analyses, as smoking data were
recorded inconsistently at varied time-points, and even
where these datawere available it was not possible to ascer-
tainwhether infants’ exposure to parental smoking had oc-
curred. Although the extent of children’s SHS exposure in
this cohort is not known, we do not anticipate that this will
have a marked effect as, in the United Kingdom since
2007, the percentage of children exposed to SHS for ‘at
least one hour a week’ has remained static at approxi-
mately 11% [22]. SHS exposure may have been more
prevalent at the start of the cohort, but it seems unlikely
that this will have had a substantial impact on ﬁndings;
nevertheless, our cost estimates are probably best viewed
as those which could be avoided if smoking in pregnancy
was eliminated permanently and women remained absti-
nent after childbirth.
We cannot discount the possibility that there are unob-
served clinical and behavioural characteristics that are
correlated positively with both smoking in pregnancy and
economic outcomes, and not accounting for them in the
models may have biased upwards the apparent effect of
smoking. A number of clinical conditions that increase
the risk of poor birth outcomes with long-term sequelae,
such as gestational hypertension [23,24], are likely to have
been present with the sample. Similarly, we did not adjust
for other risky behaviours associated with smoking in
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pregnancy, such as illicit drug or alcohol use. Illicit drug
use is not recorded reliably in routinely collected electronic
medical records and may be treated in specialist facilities
not covered by primary and secondary care records, while
the GP-enhanced services contract provides an opt-out
clause to not be involved in the treatment of drug depen-
dence [25]. As a result, drug dependence could have been
recorded differentially during the study period, and thus we
could not adjust for it reliably. Similarly, alcohol use during
pregnancy is poorly recorded and has low prevalence
(6.8%) [26], and there is some evidence of systematic mis-
classiﬁcation in routinely recorded data by doctors [27].
Therefore, the effects of illicit drug and alcohol use were
not accounted for explicitly. However, drug- and alcohol-
related problems are associated very strongly with socio-
economic deprivation, and we adjusted for this in the form
of IMD scores in all our analyses which, as a proxy for these
factors, may have reduced this bias.
Another limitation derives from linked HES data only
having being available for 12 years, resulting in relatively
few children having 10 years’ follow-up data, a compara-
tively small 10-year cohort and analyses at this time-point
having limited power. Restricting the analyses for total
costs at 1 and 5 years to a group with 10-year follow-up
data found that, although the associations were similar to
those for the unrestricted analysis, the cost coefﬁcients
did not reach statistical signiﬁcance. This may have been
due to an insufﬁcient sample size, rather than a proven
waning of the effect of smoking during pregnancy. Future,
larger studies might be necessary for a more deﬁnitive
investigation of ﬁndings at 10-year follow-up. Nevertheless,
this cohort has a substantially longer follow-up period than
the previous longest study, and as such is a substantial
contribution to the literature [9].
Results in context
Petrou et al. estimated mean hospital in-patient cost differ-
ences between children born to smokers and non-smokers
as £138, 307 and 462 during the ﬁrst 5 years of life in
women who reported smoking 1–9, 10–19 or ≥ 20 ciga-
rettes, respectively [9]. Although these cost estimates were
derived from hospital in-patient data extracted from a
limited geographical area of England (Oxford Record
Linkage Study), they are broadly similar in magnitude to
the mean total health-care cost differences we generated
[multivariable model at 5 years: £221.80 (£17.78–
425.83)]. This may reﬂect our ﬁnding that overall health-
care costs were inﬂuenced most strongly by hospital
admissions. Godfrey et al. investigated average costs for
maternal outcomes and infant outcomes attributable to
smoking and non-smoking in pregnancy [7]. Using
literature-based unit costs, infant outcomes during the ﬁrst
year of life related to smoking in pregnancy were estimated
to cost the NHS £12–23.5 million per year. Our multivari-
able model generated a mean incremental child health-
care cost attributable to maternal smoking during
pregnancy of £91.18 (£47.52–134.83) during the
ﬁrst year of life. Assuming approximately 700000 preg-
nancies per year and a UK prevalence of smoking during
pregnancy of 15% [28,29], this translates to an additional
annual health-care cost of £9.6 (£4.9–14.1) million when
the health sequelae of smoking during pregnancy are
restricted to those experienced during the ﬁrst year of life.
This represents a more conservative estimate of costs
attributable to smoking during pregnancy compared to
those derived from the published literature. When the
health sequelae of smoking during pregnancy are extended
to the ﬁrst 5 years of life, additional annual health-care
costs increase to £23.3 (£1.9–44.7) million. Overall
ﬁndings from this direct analysis of health-care use suggest
that excess infant health-care costs attributable to mater-
nal smoking in pregnancy are smaller than estimated
previously. Actual costs could be higher or lower than
our point estimates although because, as noted previously,
biases within the analyses might inﬂate or reduce derived
point estimates.
Although health beneﬁt remains the principal reason
for encouraging smoking cessation in pregnancy, our ﬁnd-
ings suggest that smoking cessation in pregnancy is also
likely to reduce the costs of providing health-care to
children. When assessing the potential economic beneﬁts
of providing stop smoking services for pregnant women,
any reduction in maternal health-care costs associated
with smoking during pregnancy should be considered in
addition to the infant and childhood ones we have quanti-
ﬁed. For example, recent estimates suggest that English
NHS Stop Smoking Services cost £235 per quitter [29],
so most of the investment made providing such services
could be recouped in the medium term by the reduced
spending on infant’s and children’s health care generated
by the smoking cessation which these services promote.
Indeed, adding in any reductions in the costs of providing
health care to pregnant women who stop smoking perma-
nently, the provision of cessation support in pregnancy
could even be cost-saving to a health system.
CONCLUSIONS
Maternal smoking in pregnancy is a leading preventable
cause of harm to mothers and babies, and we found that
it is associated with increased children’s health-care costs
during the ﬁrst 5 years of life, with elevated costs driven
primarily by more costly hospital admissions. Findings
imply that funding cessation support for pregnant smokers
could have economic beneﬁts in addition to those health
beneﬁts which accrue from permanent smoking cessation
in pregnancy.
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